The Current Ratio as of November 2024 (TTM) for Disc Medicine, Inc. (IRON) is 25.02

According to Disc Medicine, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 25.02. This represents a change of 9.11% compared to the average of 22.93 of the last 4 quarters.

Disc Medicine, Inc. (IRON) Historical Current Ratio (quarterly & annually)

How has IRON Current Ratio performed in the past?

The mean historical Current Ratio of Disc Medicine, Inc. over the last ten years is 8.71. The current 25.02 Current Ratio has changed 28.64% with respect to the historical average. Over the past ten years (40 quarters), IRON's Current Ratio was at its highest in in the September 2022 quarter at 71.49. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Disc Medicine, Inc. (IRON) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Disc Medicine, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Disc Medicine, Inc. (IRON) Average Current Ratio

How has IRON Current Ratio performed in the past?

The current Current Ratio of Disc Medicine, Inc. (IRON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Disc Medicine, Inc. (IRON) Current Ratio vs. Peers

How is IRON’s Current Ratio compared to its peers?

Disc Medicine, Inc.’s Current Ratio is greater than Anebulo Pharmaceuticals, Inc. (13.46), greater than Adagene Inc. (2.50), greater than Acrivon Therapeutics, Inc. Common Stock (16.16), greater than AnaptysBio, Inc. (9.09), greater than Mineralys Therapeutics, Inc. (11.20), greater than Olema Pharmaceuticals, Inc. (9.13), greater than Larimar Therapeutics, Inc. (13.10), greater than Fennec Pharmaceuticals Inc. (8.02), greater than Orchestra BioMed Holdings, Inc. (4.58), greater than Biomea Fusion, Inc. (3.39), less than Structure Therapeutics Inc. (41.38), less than DICE Therapeutics, Inc. (25.88), greater than Morphic Holding, Inc. (24.13), greater than Terns Pharmaceuticals, Inc. (21.02), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than Acumen Pharmaceuticals, Inc. (17.37), greater than Amylyx Pharmaceuticals, Inc. (4.66), less than MoonLake Immunotherapeutics (43.71), greater than Crinetics Pharmaceuticals, Inc. (16.09), greater than Centessa Pharmaceuticals plc (13.29), greater than Entrada Therapeutics, Inc. (5.70),

Build a custom stock screener for Disc Medicine, Inc. (IRON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Disc Medicine, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Disc Medicine, Inc. (IRON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Disc Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.